HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Is The Tide Turning For EU Prebiotics And Probiotics Regulation?

Executive Summary

More EU countries than you might think allow the terms "prebiotic" and "probiotic" on food supplement labels, suggests a survey from consultancy firm Sandwalk Bioventures. HBW Insight speaks to Sandwalk's managing director, Luis Gosalbez, about a possible move towards liberalization in the region among member states, as well as a way forward for EU regulators lagging behind this localized movement. 

You may also be interested in...



Science-Based THC Limits ‘Urgently Needed’ For EU To Compete In Global CBD Market

“We urgently need the adoption of an EU wide regulation on sound scientific THC limits in food,” insisted EIHA president and Hempro International CEO Daniel Kruse at the association's 18th annual conference, “Hemp for Europe: Emerging opportunities for the Green Recovery.”

J&J Sees ‘Enormous’ Potential In Personalized And Digitally-Supported Self-Care

J&J's senior director of medical affairs, EAME, Mark Watt, makes the case for the untapped potential of personalization through apps such as the company's Nicorette QuickMist SmartTrack product in this exclusive interview with HBW Insight. 

Fake Online Pharmacies And Sales Of Illegal COVID Tests Boom During Pandemic

Interpol and authorities in 92 countries close down over 100,000 fake online pharmacies and seize $23m worth of illegal medicines and medical devices, many of which were COVID-19 tests, as part of Operation Pangea XIV. 

Topics

UsernamePublicRestriction

Register

RS151139

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel